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ABSTRACT
Objectives: While early-onset neonatal GBS sepsis is positively associated with premature birth and
prolonged rupture of membranes, there is debate in the literature as to whether maternal GBS
colonization is a predictor of adverse obstetric outcome. This is a critical issue to resolve for
appropriate management (expectant vs. interventional management) of the patient presenting with
premature rupture ofmembranes, who has no overt signs of sepsis, but who is colonized with GBS.
Methods: Since 1981 it has been hospital policy to screen all public patients antenatally for genital
carriage of GBS by collection of a low vaginal swab at 28-32 weeks. All patients colonized with
GBS antenatally are given penicillin as intrapartum chemoprophylaxis. Review of all GBS-
colonized antenatal patients for a 12-month period (580 of 4,495 patients) and a randomized (every
fourth consecutive antenatal patient) number of noncolonized patients (958) was made. Lower
vaginal GBS colonization and other risk factors for preterm delivery were assessed using univariate
and multivariate generalized linear modeling.
Results: In the study group, the maternal GBS colonization rate was 12.9%. When cofounding
variables were controlled in a multivariate analysis, the association between antepartum GBS
colonization and preterm labor and preterm rupture of membranes was not significant.
Conclusion: Maternal antenatal carriage of GBS does not predict preterm labor. Therefore it is
appropriate that expectant management occur for a GBS-colonized woman who ruptures her
membranes, is not in labor, and has no evidence of sepsis. Infect. Dis. Obstet. Gynecol. 8:138-142,
2000. (C) 2000 Wiley-Liss, Inc.
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roup B streptococcus (GBS) is a major cause of
early-onset neonatal sepsis occurring at a rate
of 1-4 per 1,000 live births. 1,z The source ofGBS is
the maternal genital tract, where it colonizes 15-
20% of women. 1,z Obstetric risk factors associated
with early-onset neonatal GBS infections include:
premature onset of labor (< 37 weeks gestation),
prolonged rupture of the membranes (> 12 hours),
heavy maternal genital GBS colonization, multiple
births, GBS bacteriuria, presence of maternal sep-
sis, and lack of or low levels of maternal antibodies
to type-specific capsular polysaccharide of GBS se-
rotype infecting the neonate. 1-4 Yet whether ma-
ternal GBS genital colonization is a predictor of
preterm delivery or preterm rupture of membranes
is unclear, with reports from various centers finding
a positive correlation,s-8 while others have not.9-al
This is an important issue to resolve to ensure ap-
propriate management of the patient presenting
with premature rupture of membranes, who has no
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overt signs of sepsis, but who is colonized with
GBS. Consequently, whether the patient should be
managed expectantly or otherwise is debatable, lz,13
In order to prevent early-onset neonatal GBS
sepsis, it has been policy since 1981 for all public
antenatal patients at the Royal Women’s Hospital,
Melbourne, Australia to be screened antenatally for
GBS. 14 We have shown that intrapartum chemo-
prophylaxis administered to all colonized women
not only reduces neonatal GBS sepsis, but also is
cost effective. 14,as We therefore reviewed the out-
come of antenatal patients for a 12-month period,
to address the question of whether GBS genital
carriage predicts any adverse obstetric outcome and
hence assist in formulating management guidelines
for patients who are colonized with GBS, but pre-
sent with premature rupture of the membranes, are
clinically not septic, nor in labor.
SUBJECTS AND METHODS
Patient Population
The study population included all public antenatal
patients presenting to the Royal Women’s Hospi-
tal, Melbourne, Australia over a 12-month period.
It has been hospital policy to screen all public pa-
tients antenatally for genital carriage of GBS by
collection of a low vaginal swab. (Rectal cultures
have not been included in the screening protocol.)
This occurred at week 32 of gestation from 1981
and at week 28 since 1990 to date. 14 Patients found
to be colonized with GBS antepartum are given
intrapartum chemoprophylaxis (penicillin 600 mg
intravenously every 6 hours) for the length of labor
(usually 1-3 doses). Those patients with a history
of penicillin allergy are treated with erythromycin
(500 mg every 6 hours).
The histories of all GBS-colonized patients for a
12-month period were reviewed for the incidence
of premature rupture of the membranes [rupture of
membranes (ROM) before onset of labor], prema-
ture delivery (< 37 weeks of gestation), and for
recognized predisposing factors (including renal
disease, cardiac disease, pre-eclampsia, hyperten-
sion, and multiple births) that may affect obstetric
outcome.
The control population represented every
fourth consecutive antenatal patient who presented
during the same 12-month period and were found
to be negative for antenatal GBS carriage.
Microbiology
Antenatal low vaginal swabs were inoculated di-
rectly into enrichment broth (Todd-Hewitt con-
taining crystal violet, colistin, and nalidixic acid). 16
After overnight incubation, swabs were subcul-
tured onto Edwards medium (Oxoid Limited, Bas-
ingstoke, U.K.). Colonies resembling GBS were
identified by coagglutination using Phadebact
(Pharmica Diagnostics, Uppsala, Sweden) strepto-
coccal grouping reagents.
14
Statistics
Three statistical analyses were performed. These
included univariate analysis, relative risk (RR) for
GBS adjusted for a single confounder, and adjusted
RR for both GBS and all possible confounders.
The RR for GBS adjusted for a single confounder
were calculated using the method of Mantel and
Haenszel.7 The calculation of adjusted RR was
attempted via a linear model with log link and bi-
nomial family, but convergence was unattainable.
A proportional hazards model was then used as sug-
gested by Skov et al.s
RESULTS
The total live births for public patients for the 12-
month study period was 4,495 infants. Group B
streptococcal colonization of pregnant women oc-
curred in 13.0% (583) and these women formed the
study group. The control group totaled 958. In the
overall population, the projected preterm delivery
was 13.5% and with the confounders, multiple
births 5.4%, renal disease 0.9%, essential hyperten-
sion 0.6%, pre-eclampsia 8.3%, and cardiac disease
0.6%. Tables and 2 show the results for the analy-
ses for the obstetric outcome of premature delivery
by ultrasound prediction and by dates, respec-
tively. Table 3 shows the analysis of the obstetric
outcome of premature delivery (by ultrasound) to-
gether with premature preterm rupture of mem-
branes. It can be seen that there was no positive
correlation for development of premature delivery
or premature rupture of the membranes when a
woman was colonized with GBS.
Preterm delivery occurred in 8% of the study
group and 15.2% of the controls. When subdivided
into premature delivery with or without premature
rupture of membranes, these findings were less
common in those GBS-colonized women compared
to the control group. These negative associations
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TABLE I. Univariate and multivariate analyses for the obstetric outcome of premature delivery (by ultrasound)
Relative risk
Premature Crude adjusted for
Variable delivery (%) n relative risk 95% CI all confounders 95% CI
GBS carriage
Renal disease
Cardiac disease
Essential hypertension
Multiple pregnancies
PET
-ve 15.2 645
+ve 8.0 475 0.53 0.37-0.75
No 12.1 1109
Yes 18.2 1.50 0.43-5.32
No 12.2 II 12
Yes 0 8
No 12.1 II 14
Yes 16.7 6 1.38 0.23-8.29
9.7 1076
2 72.73 44 7.52 5.81-9.73
None 10.7 1023
Mild 10.6 66 1.00 0.48-2.05
Moderate 58.82 17 5.52 3.57-8.53
Severe 71.43 14 6.70 4.60-9.76
0.7 0.47-1.04
1.46 0.35-6.07
1.3 0.18-9.66
5.34 3.43-8.32
0.88 0.4 I-I .90
2.93 1.48-5.81
4.41 2.26-8.60
aAssessable patients for all variables.
TABLE 2. Univariate and multivariate analyses for the obstetric outcome of premature delivery (by dates)
Relative risk
Premature Crude adjusted for
Variable delivery (%) n relative risk 95% CI all confounders 95% CI
GBS carriage
Renal disease
Cardiac disease
Essential hypertension
Multiple pregnancies
PET
-ve 13.5 764
+ve 6.7 449 0.5 0.34-0.73
No 10.9 1199
Yes 14.29 14 1.31 0.36-4.77
No 1.0 1205
Yes 0 8
No 1.0 1205
Yes 0 9
8.8 1165
2 62.5 48 7.07 5.3 I-9.41
None 10.2 1104
Mild 10.4 77 1.02 0.5 I-2.00
Moderate 20.0 15 1.95 0.70-5.46
Severe 52.94 17 5.17 3.20
0.62 0.41-0.95
1.43 0.34-5.93
5.79 3.72-9.01
0.81 0.39-1.67
2.67 0.84-8.48
2.53 1.23-5.19
aAssessable patients for all variables.
TABLE 3. Univariate and multivariate analyses for the obstetric outcome of premature delivery (by
ultrasound) and preterm premature rupture of membranes
Premature Crude Relative
Variable delivery (%) n" relative risk 95% CI risk adjusted 95% CI
GBS carriage -ve 3. 923
+ve 1.4 583 0.44 0.20-0.95 0.61 0.27-1.317
aAssessable patients for all variables.
with GBS colonization and obstetric outcomes car-
ried through from the univariate to the multivariate
analysis when adjustment for all confounders was
made. (However the 95% confidence intervals for
the relative risk adjustments were not significant as
they were on either side of 1.)
There were ten infants with GBS sepsis for this
period. One was a late-onset urinary tract infection
(infection at day 22 of life of a child born at 27
weeks gestation), and one was stillborn (the infant
was 37 weeks gestation at birth and the mother had
been recognized antenatally as a GBS carrier; pla-
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cental histology showed chorioamnionitis, and pla-
cental membranes grew GBS, as did infant tissues
of liver, lung, and spleen). Of the eight infants with
early-onset sepsis, five were septicaemic with
pneumonia (weeks 33, 33, 36, 37 and 40 gestation)
and all survived; two had pneumonia alone (weeks
33 and 40 gestation).
Of the eight early-onset neonatal cases, the
mothers were not screened for GBS, as they were
private patients (not universal policy to screen) or
non-booked transfers from other institotions. The
one public patient developed maternal sepsis with
GBS at 33 weeks gestation. The mother was
treated, intrapartum because of prolonged rupture
of membranes (48 hours) and maternal fever.
DISCUSSION
There is much evidence that intra-amniotic infec-
tion (either asymptomatic or clinically apparent) is
involved in the pathogenesis of preterm delivery
and premature rupture of membranes. More spe-
cifically, bacterial products such as phospholipases
Ae and C, endotoxin, and induction of the cytokine
cascade, can stimulate the prostaglandin pathway
and initiate labor. 19-zl Furthermore, an experimen-
tal animal model in rhesus monkeys for intra-
amniotic GBS infection and preterm labor supports
this concept,zz
Yet vaginal GBS carriage alone does not neces-
sarily equate with ascending infection, intra-
amniotic infection, and prematurity.
We were unable to find a positive correlation
with adverse pregnancy outcome for those women
colonized antenatally with GBS. These findings
concur with those of various other authors.9-1,z3 In
particular, Chua et al. reported a similar GBS colo-
nization rate of 14% in their antenatal patients and
found no significantly higher incidence for preterm
and/or prelabor rupture of membranes in women
with GBS carriage, compared with a negative
group,e3
Similarly, Regan et al., in a recent report from
the VIP Study Group where they specifically ex-
amined cervicovaginal GBS colonization at 23-26
weeks gestation in a multicenter study, found no
adverse pregnancy outcome except for the sub-
group for those with heavy GBS colonization.
Unfortunately, we were unable to analyze our
data with respect to the degree of GBS coloniza-
tion, as low vaginal swabs were directly inoculated
into an enrichment broth and subcultured on to a
selective medium, but without making any quan-
titative assessments. Furthermore, rectal swabs
were not part of our screening protocol and there-
fore the GBS carriage rate may well have been an
underestimate. Rectal swabs have had a low accep-
tance rate by patients and obstetricians. However,
swabs collected are low vaginal (almost perineal).
Our findings may be explained in part by the
variable nature of genital GBS carriage throughout
pregnancy. Many researchers have documented
that the sensitivity of antenatal GBS screening for
carriage at delivery is in the order of 60-70%.3,624
Furthermore, of those negative at 26-28 weeks
gestation, 6-8.5% will be positive at delivery.3,4
Perhaps those most at risk are women who are per-
sistently colonized with a high bacterial load, yet
have not made specific antibody to their colonizing
strain of GBS. A more recently recognized risk fac-
tor of premature delivery is the presence of bacte-
rial vaginosis and this finding could be a con-
founder in our data.9 However, we have not been
screening our antenatal population for bacterial
vaginosis, and hence cannot analyze our findings of
premature delivery findings with respect to this
entity.
Therefore, a suitable management plan when
finding GBS colonization in the presence of unex-
plained preterm rupture of the membranes, but
with no evidence of sepsis or labor, could be to
commence the patient on a five-day course of peni-
cillin, observe carefully for evidence of sepsis, but
to not induce labor on these grounds alone.
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